4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-061162
President sold 100,000 shares at $125.00 ($12,500,000)
- President acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-11-30 | Option exercise | +50,000 | $14.00 | $700,000 | 698,007 | D |
| Novak Rodger President | 2020-11-30 | Sale | −50,000 | $125.00 | $6,250,000 | 648,007 | D |
| Novak Rodger President | 2020-11-30 | Option exercise | +50,000 | $14.43 | $721,500 | 698,007 | D |
| Novak Rodger President | 2020-11-30 | Sale | −50,000 | $125.00 | $6,250,000 | 648,007 | D |
| Derivatives | |||||||
| Novak Rodger President | 2020-11-30 | Option exercise · Stock Option (Right to Buy) | −50,000 | 61,893 | D | ||
| Novak Rodger President | 2020-11-30 | Option exercise · Stock Option (Right to Buy) | −50,000 | 140,315 | D | ||
| Open-market sales · 100,000 sh · avg $125.00 · $12,500,000 | |||||||
Loading xslF345X03/doc4.xml…